Global Monoclonal Antibody Medicine Market Research Report 2024, Forecast to 2032
Report Overview
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
The global Monoclonal Antibody Medicine market size was estimated at USD 216310 million in 2023 and is projected to reach USD 599844.67 million by 2032, exhibiting a CAGR of 12.00% during the forecast period.
North America Monoclonal Antibody Medicine market size was estimated at USD 68555.44 million in 2023, at a CAGR of 10.29% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Monoclonal Antibody Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody Medicine market in any manner.
Global Monoclonal Antibody Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Market Segmentation (by Type)
Biologics
Biosimilars
Market Segmentation (by Application)
Cancer
Autoimmune Disease
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Monoclonal Antibody Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
The global Monoclonal Antibody Medicine market size was estimated at USD 216310 million in 2023 and is projected to reach USD 599844.67 million by 2032, exhibiting a CAGR of 12.00% during the forecast period.
North America Monoclonal Antibody Medicine market size was estimated at USD 68555.44 million in 2023, at a CAGR of 10.29% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Monoclonal Antibody Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Monoclonal Antibody Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Monoclonal Antibody Medicine market in any manner.
Global Monoclonal Antibody Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Pfizer
Eli Lilly
Novartis
Merck
Biogen
Celltrion
Sobi
3SBIO
Innovent Biologics
Market Segmentation (by Type)
Biologics
Biosimilars
Market Segmentation (by Application)
Cancer
Autoimmune Disease
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Monoclonal Antibody Medicine Market
- Overview of the regional outlook of the Monoclonal Antibody Medicine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Monoclonal Antibody Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Monoclonal Antibody Medicine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Medicine
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Medicine Segment by Type
1.2.2 Monoclonal Antibody Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Medicine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Monoclonal Antibody Medicine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody Medicine Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody Medicine Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Medicine Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Medicine Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody Medicine Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Medicine Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY MEDICINE MARKET CONSUMPTION BY REGION
8.1 Global Monoclonal Antibody Medicine Sales by Region
8.1.1 Global Monoclonal Antibody Medicine Sales by Region
8.1.2 Global Monoclonal Antibody Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MONOCLONAL ANTIBODY MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Monoclonal Antibody Medicine by Region (2019-2024)
9.2 Global Monoclonal Antibody Medicine Revenue Market Share by Region (2019-2024)
9.3 Global Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Monoclonal Antibody Medicine Production
9.4.1 North America Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.4.2 North America Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Monoclonal Antibody Medicine Production
9.5.1 Europe Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.5.2 Europe Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Monoclonal Antibody Medicine Production (2019-2024)
9.6.1 Japan Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.6.2 Japan Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Monoclonal Antibody Medicine Production (2019-2024)
9.7.1 China Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.7.2 China Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Monoclonal Antibody Medicine Basic Information
10.1.2 Roche Monoclonal Antibody Medicine Product Overview
10.1.3 Roche Monoclonal Antibody Medicine Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Monoclonal Antibody Medicine SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Amgen
10.2.1 Amgen Monoclonal Antibody Medicine Basic Information
10.2.2 Amgen Monoclonal Antibody Medicine Product Overview
10.2.3 Amgen Monoclonal Antibody Medicine Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Monoclonal Antibody Medicine SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 AbbVie
10.3.1 AbbVie Monoclonal Antibody Medicine Basic Information
10.3.2 AbbVie Monoclonal Antibody Medicine Product Overview
10.3.3 AbbVie Monoclonal Antibody Medicine Product Market Performance
10.3.4 AbbVie Monoclonal Antibody Medicine SWOT Analysis
10.3.5 AbbVie Business Overview
10.3.6 AbbVie Recent Developments
10.4 Sanofi
10.4.1 Sanofi Monoclonal Antibody Medicine Basic Information
10.4.2 Sanofi Monoclonal Antibody Medicine Product Overview
10.4.3 Sanofi Monoclonal Antibody Medicine Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Johnson and Johnson
10.5.1 Johnson and Johnson Monoclonal Antibody Medicine Basic Information
10.5.2 Johnson and Johnson Monoclonal Antibody Medicine Product Overview
10.5.3 Johnson and Johnson Monoclonal Antibody Medicine Product Market Performance
10.5.4 Johnson and Johnson Business Overview
10.5.5 Johnson and Johnson Recent Developments
10.6 Pfizer
10.6.1 Pfizer Monoclonal Antibody Medicine Basic Information
10.6.2 Pfizer Monoclonal Antibody Medicine Product Overview
10.6.3 Pfizer Monoclonal Antibody Medicine Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Eli Lilly
10.7.1 Eli Lilly Monoclonal Antibody Medicine Basic Information
10.7.2 Eli Lilly Monoclonal Antibody Medicine Product Overview
10.7.3 Eli Lilly Monoclonal Antibody Medicine Product Market Performance
10.7.4 Eli Lilly Business Overview
10.7.5 Eli Lilly Recent Developments
10.8 Novartis
10.8.1 Novartis Monoclonal Antibody Medicine Basic Information
10.8.2 Novartis Monoclonal Antibody Medicine Product Overview
10.8.3 Novartis Monoclonal Antibody Medicine Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Merck
10.9.1 Merck Monoclonal Antibody Medicine Basic Information
10.9.2 Merck Monoclonal Antibody Medicine Product Overview
10.9.3 Merck Monoclonal Antibody Medicine Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Biogen
10.10.1 Biogen Monoclonal Antibody Medicine Basic Information
10.10.2 Biogen Monoclonal Antibody Medicine Product Overview
10.10.3 Biogen Monoclonal Antibody Medicine Product Market Performance
10.10.4 Biogen Business Overview
10.10.5 Biogen Recent Developments
10.11 Celltrion
10.11.1 Celltrion Monoclonal Antibody Medicine Basic Information
10.11.2 Celltrion Monoclonal Antibody Medicine Product Overview
10.11.3 Celltrion Monoclonal Antibody Medicine Product Market Performance
10.11.4 Celltrion Business Overview
10.11.5 Celltrion Recent Developments
10.12 Sobi
10.12.1 Sobi Monoclonal Antibody Medicine Basic Information
10.12.2 Sobi Monoclonal Antibody Medicine Product Overview
10.12.3 Sobi Monoclonal Antibody Medicine Product Market Performance
10.12.4 Sobi Business Overview
10.12.5 Sobi Recent Developments
10.13 3SBIO
10.13.1 3SBIO Monoclonal Antibody Medicine Basic Information
10.13.2 3SBIO Monoclonal Antibody Medicine Product Overview
10.13.3 3SBIO Monoclonal Antibody Medicine Product Market Performance
10.13.4 3SBIO Business Overview
10.13.5 3SBIO Recent Developments
10.14 Innovent Biologics
10.14.1 Innovent Biologics Monoclonal Antibody Medicine Basic Information
10.14.2 Innovent Biologics Monoclonal Antibody Medicine Product Overview
10.14.3 Innovent Biologics Monoclonal Antibody Medicine Product Market Performance
10.14.4 Innovent Biologics Business Overview
10.14.5 Innovent Biologics Recent Developments
11 MONOCLONAL ANTIBODY MEDICINE MARKET FORECAST BY REGION
11.1 Global Monoclonal Antibody Medicine Market Size Forecast
11.2 Global Monoclonal Antibody Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Monoclonal Antibody Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Monoclonal Antibody Medicine Market Size Forecast by Region
11.2.4 South America Monoclonal Antibody Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Monoclonal Antibody Medicine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Monoclonal Antibody Medicine by Type (2025-2032)
12.1.2 Global Monoclonal Antibody Medicine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Monoclonal Antibody Medicine by Type (2025-2032)
12.2 Global Monoclonal Antibody Medicine Market Forecast by Application (2025-2032)
12.2.1 Global Monoclonal Antibody Medicine Sales (K MT) Forecast by Application
12.2.2 Global Monoclonal Antibody Medicine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Monoclonal Antibody Medicine
1.2 Key Market Segments
1.2.1 Monoclonal Antibody Medicine Segment by Type
1.2.2 Monoclonal Antibody Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MONOCLONAL ANTIBODY MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Monoclonal Antibody Medicine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Monoclonal Antibody Medicine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MONOCLONAL ANTIBODY MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Monoclonal Antibody Medicine Sales by Manufacturers (2019-2024)
3.2 Global Monoclonal Antibody Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Monoclonal Antibody Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Monoclonal Antibody Medicine Sales Sites, Area Served, Product Type
3.6 Monoclonal Antibody Medicine Market Competitive Situation and Trends
3.6.1 Monoclonal Antibody Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Monoclonal Antibody Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MONOCLONAL ANTIBODY MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Monoclonal Antibody Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MONOCLONAL ANTIBODY MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MONOCLONAL ANTIBODY MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Monoclonal Antibody Medicine Sales Market Share by Type (2019-2024)
6.3 Global Monoclonal Antibody Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Monoclonal Antibody Medicine Price by Type (2019-2024)
7 MONOCLONAL ANTIBODY MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Monoclonal Antibody Medicine Market Sales by Application (2019-2024)
7.3 Global Monoclonal Antibody Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
8 MONOCLONAL ANTIBODY MEDICINE MARKET CONSUMPTION BY REGION
8.1 Global Monoclonal Antibody Medicine Sales by Region
8.1.1 Global Monoclonal Antibody Medicine Sales by Region
8.1.2 Global Monoclonal Antibody Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Monoclonal Antibody Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Monoclonal Antibody Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Monoclonal Antibody Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Monoclonal Antibody Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Monoclonal Antibody Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 MONOCLONAL ANTIBODY MEDICINE MARKET PRODUCTION BY REGION
9.1 Global Production of Monoclonal Antibody Medicine by Region (2019-2024)
9.2 Global Monoclonal Antibody Medicine Revenue Market Share by Region (2019-2024)
9.3 Global Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Monoclonal Antibody Medicine Production
9.4.1 North America Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.4.2 North America Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Monoclonal Antibody Medicine Production
9.5.1 Europe Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.5.2 Europe Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Monoclonal Antibody Medicine Production (2019-2024)
9.6.1 Japan Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.6.2 Japan Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Monoclonal Antibody Medicine Production (2019-2024)
9.7.1 China Monoclonal Antibody Medicine Production Growth Rate (2019-2024)
9.7.2 China Monoclonal Antibody Medicine Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Monoclonal Antibody Medicine Basic Information
10.1.2 Roche Monoclonal Antibody Medicine Product Overview
10.1.3 Roche Monoclonal Antibody Medicine Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche Monoclonal Antibody Medicine SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Amgen
10.2.1 Amgen Monoclonal Antibody Medicine Basic Information
10.2.2 Amgen Monoclonal Antibody Medicine Product Overview
10.2.3 Amgen Monoclonal Antibody Medicine Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen Monoclonal Antibody Medicine SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 AbbVie
10.3.1 AbbVie Monoclonal Antibody Medicine Basic Information
10.3.2 AbbVie Monoclonal Antibody Medicine Product Overview
10.3.3 AbbVie Monoclonal Antibody Medicine Product Market Performance
10.3.4 AbbVie Monoclonal Antibody Medicine SWOT Analysis
10.3.5 AbbVie Business Overview
10.3.6 AbbVie Recent Developments
10.4 Sanofi
10.4.1 Sanofi Monoclonal Antibody Medicine Basic Information
10.4.2 Sanofi Monoclonal Antibody Medicine Product Overview
10.4.3 Sanofi Monoclonal Antibody Medicine Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Johnson and Johnson
10.5.1 Johnson and Johnson Monoclonal Antibody Medicine Basic Information
10.5.2 Johnson and Johnson Monoclonal Antibody Medicine Product Overview
10.5.3 Johnson and Johnson Monoclonal Antibody Medicine Product Market Performance
10.5.4 Johnson and Johnson Business Overview
10.5.5 Johnson and Johnson Recent Developments
10.6 Pfizer
10.6.1 Pfizer Monoclonal Antibody Medicine Basic Information
10.6.2 Pfizer Monoclonal Antibody Medicine Product Overview
10.6.3 Pfizer Monoclonal Antibody Medicine Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Eli Lilly
10.7.1 Eli Lilly Monoclonal Antibody Medicine Basic Information
10.7.2 Eli Lilly Monoclonal Antibody Medicine Product Overview
10.7.3 Eli Lilly Monoclonal Antibody Medicine Product Market Performance
10.7.4 Eli Lilly Business Overview
10.7.5 Eli Lilly Recent Developments
10.8 Novartis
10.8.1 Novartis Monoclonal Antibody Medicine Basic Information
10.8.2 Novartis Monoclonal Antibody Medicine Product Overview
10.8.3 Novartis Monoclonal Antibody Medicine Product Market Performance
10.8.4 Novartis Business Overview
10.8.5 Novartis Recent Developments
10.9 Merck
10.9.1 Merck Monoclonal Antibody Medicine Basic Information
10.9.2 Merck Monoclonal Antibody Medicine Product Overview
10.9.3 Merck Monoclonal Antibody Medicine Product Market Performance
10.9.4 Merck Business Overview
10.9.5 Merck Recent Developments
10.10 Biogen
10.10.1 Biogen Monoclonal Antibody Medicine Basic Information
10.10.2 Biogen Monoclonal Antibody Medicine Product Overview
10.10.3 Biogen Monoclonal Antibody Medicine Product Market Performance
10.10.4 Biogen Business Overview
10.10.5 Biogen Recent Developments
10.11 Celltrion
10.11.1 Celltrion Monoclonal Antibody Medicine Basic Information
10.11.2 Celltrion Monoclonal Antibody Medicine Product Overview
10.11.3 Celltrion Monoclonal Antibody Medicine Product Market Performance
10.11.4 Celltrion Business Overview
10.11.5 Celltrion Recent Developments
10.12 Sobi
10.12.1 Sobi Monoclonal Antibody Medicine Basic Information
10.12.2 Sobi Monoclonal Antibody Medicine Product Overview
10.12.3 Sobi Monoclonal Antibody Medicine Product Market Performance
10.12.4 Sobi Business Overview
10.12.5 Sobi Recent Developments
10.13 3SBIO
10.13.1 3SBIO Monoclonal Antibody Medicine Basic Information
10.13.2 3SBIO Monoclonal Antibody Medicine Product Overview
10.13.3 3SBIO Monoclonal Antibody Medicine Product Market Performance
10.13.4 3SBIO Business Overview
10.13.5 3SBIO Recent Developments
10.14 Innovent Biologics
10.14.1 Innovent Biologics Monoclonal Antibody Medicine Basic Information
10.14.2 Innovent Biologics Monoclonal Antibody Medicine Product Overview
10.14.3 Innovent Biologics Monoclonal Antibody Medicine Product Market Performance
10.14.4 Innovent Biologics Business Overview
10.14.5 Innovent Biologics Recent Developments
11 MONOCLONAL ANTIBODY MEDICINE MARKET FORECAST BY REGION
11.1 Global Monoclonal Antibody Medicine Market Size Forecast
11.2 Global Monoclonal Antibody Medicine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Monoclonal Antibody Medicine Market Size Forecast by Country
11.2.3 Asia Pacific Monoclonal Antibody Medicine Market Size Forecast by Region
11.2.4 South America Monoclonal Antibody Medicine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Monoclonal Antibody Medicine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Monoclonal Antibody Medicine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Monoclonal Antibody Medicine by Type (2025-2032)
12.1.2 Global Monoclonal Antibody Medicine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Monoclonal Antibody Medicine by Type (2025-2032)
12.2 Global Monoclonal Antibody Medicine Market Forecast by Application (2025-2032)
12.2.1 Global Monoclonal Antibody Medicine Sales (K MT) Forecast by Application
12.2.2 Global Monoclonal Antibody Medicine Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Medicine Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Medicine Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Medicine as of 2022)
Table 10. Global Market Monoclonal Antibody Medicine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody Medicine Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Medicine Product Type
Table 13. Global Monoclonal Antibody Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Medicine Market Challenges
Table 22. Global Monoclonal Antibody Medicine Sales by Type (K MT)
Table 23. Global Monoclonal Antibody Medicine Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Medicine Sales (K MT) by Type (2019-2024)
Table 25. Global Monoclonal Antibody Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody Medicine Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody Medicine Price (USD/MT) by Type (2019-2024)
Table 29. Global Monoclonal Antibody Medicine Sales (K MT) by Application
Table 30. Global Monoclonal Antibody Medicine Market Size by Application
Table 31. Global Monoclonal Antibody Medicine Sales by Application (2019-2024) & (K MT)
Table 32. Global Monoclonal Antibody Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody Medicine Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 37. Global Monoclonal Antibody Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 39. Europe Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 41. South America Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 43. Global Monoclonal Antibody Medicine Production (K MT) by Region (2019-2024)
Table 44. Global Monoclonal Antibody Medicine Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Monoclonal Antibody Medicine Revenue Market Share by Region (2019-2024)
Table 46. Global Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Monoclonal Antibody Medicine Basic Information
Table 52. Roche Monoclonal Antibody Medicine Product Overview
Table 53. Roche Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Monoclonal Antibody Medicine SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Amgen Monoclonal Antibody Medicine Basic Information
Table 58. Amgen Monoclonal Antibody Medicine Product Overview
Table 59. Amgen Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Amgen Business Overview
Table 61. Amgen Monoclonal Antibody Medicine SWOT Analysis
Table 62. Amgen Recent Developments
Table 63. AbbVie Monoclonal Antibody Medicine Basic Information
Table 64. AbbVie Monoclonal Antibody Medicine Product Overview
Table 65. AbbVie Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AbbVie Monoclonal Antibody Medicine SWOT Analysis
Table 67. AbbVie Business Overview
Table 68. AbbVie Recent Developments
Table 69. Sanofi Monoclonal Antibody Medicine Basic Information
Table 70. Sanofi Monoclonal Antibody Medicine Product Overview
Table 71. Sanofi Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Johnson and Johnson Monoclonal Antibody Medicine Basic Information
Table 75. Johnson and Johnson Monoclonal Antibody Medicine Product Overview
Table 76. Johnson and Johnson Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Recent Developments
Table 79. Pfizer Monoclonal Antibody Medicine Basic Information
Table 80. Pfizer Monoclonal Antibody Medicine Product Overview
Table 81. Pfizer Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Eli Lilly Monoclonal Antibody Medicine Basic Information
Table 85. Eli Lilly Monoclonal Antibody Medicine Product Overview
Table 86. Eli Lilly Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Recent Developments
Table 89. Novartis Monoclonal Antibody Medicine Basic Information
Table 90. Novartis Monoclonal Antibody Medicine Product Overview
Table 91. Novartis Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Merck Monoclonal Antibody Medicine Basic Information
Table 95. Merck Monoclonal Antibody Medicine Product Overview
Table 96. Merck Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Merck Business Overview
Table 98. Merck Recent Developments
Table 99. Biogen Monoclonal Antibody Medicine Basic Information
Table 100. Biogen Monoclonal Antibody Medicine Product Overview
Table 101. Biogen Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Biogen Business Overview
Table 103. Biogen Recent Developments
Table 104. Celltrion Monoclonal Antibody Medicine Basic Information
Table 105. Celltrion Monoclonal Antibody Medicine Product Overview
Table 106. Celltrion Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Celltrion Business Overview
Table 108. Celltrion Recent Developments
Table 109. Sobi Monoclonal Antibody Medicine Basic Information
Table 110. Sobi Monoclonal Antibody Medicine Product Overview
Table 111. Sobi Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Sobi Business Overview
Table 113. Sobi Recent Developments
Table 114. 3SBIO Monoclonal Antibody Medicine Basic Information
Table 115. 3SBIO Monoclonal Antibody Medicine Product Overview
Table 116. 3SBIO Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. 3SBIO Business Overview
Table 118. 3SBIO Recent Developments
Table 119. Innovent Biologics Monoclonal Antibody Medicine Basic Information
Table 120. Innovent Biologics Monoclonal Antibody Medicine Product Overview
Table 121. Innovent Biologics Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Innovent Biologics Business Overview
Table 123. Innovent Biologics Recent Developments
Table 124. Global Monoclonal Antibody Medicine Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Monoclonal Antibody Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Monoclonal Antibody Medicine Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Monoclonal Antibody Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Monoclonal Antibody Medicine Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Monoclonal Antibody Medicine Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Monoclonal Antibody Medicine Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Monoclonal Antibody Medicine Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Monoclonal Antibody Medicine Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Monoclonal Antibody Medicine Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Monoclonal Antibody Medicine Market Size Comparison by Region (M USD)
Table 5. Global Monoclonal Antibody Medicine Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Monoclonal Antibody Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Monoclonal Antibody Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Monoclonal Antibody Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monoclonal Antibody Medicine as of 2022)
Table 10. Global Market Monoclonal Antibody Medicine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Monoclonal Antibody Medicine Sales Sites and Area Served
Table 12. Manufacturers Monoclonal Antibody Medicine Product Type
Table 13. Global Monoclonal Antibody Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Monoclonal Antibody Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Monoclonal Antibody Medicine Market Challenges
Table 22. Global Monoclonal Antibody Medicine Sales by Type (K MT)
Table 23. Global Monoclonal Antibody Medicine Market Size by Type (M USD)
Table 24. Global Monoclonal Antibody Medicine Sales (K MT) by Type (2019-2024)
Table 25. Global Monoclonal Antibody Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Monoclonal Antibody Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Monoclonal Antibody Medicine Market Size Share by Type (2019-2024)
Table 28. Global Monoclonal Antibody Medicine Price (USD/MT) by Type (2019-2024)
Table 29. Global Monoclonal Antibody Medicine Sales (K MT) by Application
Table 30. Global Monoclonal Antibody Medicine Market Size by Application
Table 31. Global Monoclonal Antibody Medicine Sales by Application (2019-2024) & (K MT)
Table 32. Global Monoclonal Antibody Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Monoclonal Antibody Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Monoclonal Antibody Medicine Market Share by Application (2019-2024)
Table 35. Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 37. Global Monoclonal Antibody Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 39. Europe Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 41. South America Monoclonal Antibody Medicine Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Monoclonal Antibody Medicine Sales by Region (2019-2024) & (K MT)
Table 43. Global Monoclonal Antibody Medicine Production (K MT) by Region (2019-2024)
Table 44. Global Monoclonal Antibody Medicine Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Monoclonal Antibody Medicine Revenue Market Share by Region (2019-2024)
Table 46. Global Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Monoclonal Antibody Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Roche Monoclonal Antibody Medicine Basic Information
Table 52. Roche Monoclonal Antibody Medicine Product Overview
Table 53. Roche Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Roche Business Overview
Table 55. Roche Monoclonal Antibody Medicine SWOT Analysis
Table 56. Roche Recent Developments
Table 57. Amgen Monoclonal Antibody Medicine Basic Information
Table 58. Amgen Monoclonal Antibody Medicine Product Overview
Table 59. Amgen Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Amgen Business Overview
Table 61. Amgen Monoclonal Antibody Medicine SWOT Analysis
Table 62. Amgen Recent Developments
Table 63. AbbVie Monoclonal Antibody Medicine Basic Information
Table 64. AbbVie Monoclonal Antibody Medicine Product Overview
Table 65. AbbVie Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. AbbVie Monoclonal Antibody Medicine SWOT Analysis
Table 67. AbbVie Business Overview
Table 68. AbbVie Recent Developments
Table 69. Sanofi Monoclonal Antibody Medicine Basic Information
Table 70. Sanofi Monoclonal Antibody Medicine Product Overview
Table 71. Sanofi Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Sanofi Business Overview
Table 73. Sanofi Recent Developments
Table 74. Johnson and Johnson Monoclonal Antibody Medicine Basic Information
Table 75. Johnson and Johnson Monoclonal Antibody Medicine Product Overview
Table 76. Johnson and Johnson Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson Recent Developments
Table 79. Pfizer Monoclonal Antibody Medicine Basic Information
Table 80. Pfizer Monoclonal Antibody Medicine Product Overview
Table 81. Pfizer Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Pfizer Business Overview
Table 83. Pfizer Recent Developments
Table 84. Eli Lilly Monoclonal Antibody Medicine Basic Information
Table 85. Eli Lilly Monoclonal Antibody Medicine Product Overview
Table 86. Eli Lilly Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Recent Developments
Table 89. Novartis Monoclonal Antibody Medicine Basic Information
Table 90. Novartis Monoclonal Antibody Medicine Product Overview
Table 91. Novartis Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Novartis Business Overview
Table 93. Novartis Recent Developments
Table 94. Merck Monoclonal Antibody Medicine Basic Information
Table 95. Merck Monoclonal Antibody Medicine Product Overview
Table 96. Merck Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. Merck Business Overview
Table 98. Merck Recent Developments
Table 99. Biogen Monoclonal Antibody Medicine Basic Information
Table 100. Biogen Monoclonal Antibody Medicine Product Overview
Table 101. Biogen Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Biogen Business Overview
Table 103. Biogen Recent Developments
Table 104. Celltrion Monoclonal Antibody Medicine Basic Information
Table 105. Celltrion Monoclonal Antibody Medicine Product Overview
Table 106. Celltrion Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Celltrion Business Overview
Table 108. Celltrion Recent Developments
Table 109. Sobi Monoclonal Antibody Medicine Basic Information
Table 110. Sobi Monoclonal Antibody Medicine Product Overview
Table 111. Sobi Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. Sobi Business Overview
Table 113. Sobi Recent Developments
Table 114. 3SBIO Monoclonal Antibody Medicine Basic Information
Table 115. 3SBIO Monoclonal Antibody Medicine Product Overview
Table 116. 3SBIO Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. 3SBIO Business Overview
Table 118. 3SBIO Recent Developments
Table 119. Innovent Biologics Monoclonal Antibody Medicine Basic Information
Table 120. Innovent Biologics Monoclonal Antibody Medicine Product Overview
Table 121. Innovent Biologics Monoclonal Antibody Medicine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Innovent Biologics Business Overview
Table 123. Innovent Biologics Recent Developments
Table 124. Global Monoclonal Antibody Medicine Sales Forecast by Region (2025-2032) & (K MT)
Table 125. Global Monoclonal Antibody Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 126. North America Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 127. North America Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 128. Europe Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 129. Europe Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 130. Asia Pacific Monoclonal Antibody Medicine Sales Forecast by Region (2025-2032) & (K MT)
Table 131. Asia Pacific Monoclonal Antibody Medicine Market Size Forecast by Region (2025-2032) & (M USD)
Table 132. South America Monoclonal Antibody Medicine Sales Forecast by Country (2025-2032) & (K MT)
Table 133. South America Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 134. Middle East and Africa Monoclonal Antibody Medicine Consumption Forecast by Country (2025-2032) & (Units)
Table 135. Middle East and Africa Monoclonal Antibody Medicine Market Size Forecast by Country (2025-2032) & (M USD)
Table 136. Global Monoclonal Antibody Medicine Sales Forecast by Type (2025-2032) & (K MT)
Table 137. Global Monoclonal Antibody Medicine Market Size Forecast by Type (2025-2032) & (M USD)
Table 138. Global Monoclonal Antibody Medicine Price Forecast by Type (2025-2032) & (USD/MT)
Table 139. Global Monoclonal Antibody Medicine Sales (K MT) Forecast by Application (2025-2032)
Table 140. Global Monoclonal Antibody Medicine Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Monoclonal Antibody Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Medicine Market Size (M USD), 2019-2032
Figure 5. Global Monoclonal Antibody Medicine Market Size (M USD) (2019-2032)
Figure 6. Global Monoclonal Antibody Medicine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Medicine Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Medicine Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Medicine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Medicine Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody Medicine by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Medicine Market Share by Application
Figure 24. Global Monoclonal Antibody Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody Medicine Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Medicine Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody Medicine Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Monoclonal Antibody Medicine Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Monoclonal Antibody Medicine Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 50. South America Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Monoclonal Antibody Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Monoclonal Antibody Medicine Production Market Share by Region (2019-2024)
Figure 62. North America Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 65. China Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Monoclonal Antibody Medicine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Monoclonal Antibody Medicine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Monoclonal Antibody Medicine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Monoclonal Antibody Medicine Market Share Forecast by Type (2025-2032)
Figure 70. Global Monoclonal Antibody Medicine Sales Forecast by Application (2025-2032)
Figure 71. Global Monoclonal Antibody Medicine Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Monoclonal Antibody Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Monoclonal Antibody Medicine Market Size (M USD), 2019-2032
Figure 5. Global Monoclonal Antibody Medicine Market Size (M USD) (2019-2032)
Figure 6. Global Monoclonal Antibody Medicine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Monoclonal Antibody Medicine Market Size by Country (M USD)
Figure 11. Monoclonal Antibody Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Monoclonal Antibody Medicine Revenue Share by Manufacturers in 2023
Figure 13. Monoclonal Antibody Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Monoclonal Antibody Medicine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Monoclonal Antibody Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Monoclonal Antibody Medicine Market Share by Type
Figure 18. Sales Market Share of Monoclonal Antibody Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Monoclonal Antibody Medicine by Type in 2023
Figure 20. Market Size Share of Monoclonal Antibody Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Monoclonal Antibody Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Monoclonal Antibody Medicine Market Share by Application
Figure 24. Global Monoclonal Antibody Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Monoclonal Antibody Medicine Sales Market Share by Application in 2023
Figure 26. Global Monoclonal Antibody Medicine Market Share by Application (2019-2024)
Figure 27. Global Monoclonal Antibody Medicine Market Share by Application in 2023
Figure 28. Global Monoclonal Antibody Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Monoclonal Antibody Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Monoclonal Antibody Medicine Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Monoclonal Antibody Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 37. Germany Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Monoclonal Antibody Medicine Sales Market Share by Region in 2023
Figure 44. China Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 50. South America Monoclonal Antibody Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Monoclonal Antibody Medicine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Monoclonal Antibody Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Monoclonal Antibody Medicine Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Monoclonal Antibody Medicine Production Market Share by Region (2019-2024)
Figure 62. North America Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 65. China Monoclonal Antibody Medicine Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Monoclonal Antibody Medicine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Monoclonal Antibody Medicine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Monoclonal Antibody Medicine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Monoclonal Antibody Medicine Market Share Forecast by Type (2025-2032)
Figure 70. Global Monoclonal Antibody Medicine Sales Forecast by Application (2025-2032)
Figure 71. Global Monoclonal Antibody Medicine Market Share Forecast by Application (2025-2032)
